Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation (Q44712560)

5 December 2017

title

Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation (English)

1 reference

5 December 2017

4

1 reference

5 December 2017

5

Ueli Aebi

1 reference

5 December 2017

Janelle D Green

1

1 reference

5 December 2017

Claire Goldsbury

series ordinal

2

1 reference

5 December 2017

Joerg Kistler

series ordinal

3

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Journal of Biological Chemistry

5 December 2017

published in

1 reference

5 December 2017

volume

279

1 reference

5 December 2017

issue

13

1 reference

5 December 2017

page(s)

12206-12212

1 reference

Review: history of the amyloid fibril

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Calcitonin gene-related peptide is a potent vasodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Identification of prion amyloid filaments in scrapie-infected brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Neurotoxicity of a prion protein fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Amyloid peptides are toxic via a common oxidative mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Surface-catalyzed amyloid fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Structure determination of micelle-like intermediates in amyloid beta -protein fibril assembly by using small angle neutron scattering

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Assembly of amyloid protofibrils via critical oligomers--a novel pathway of amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M312452200

21 January 2018

Identifiers

DOI

10.1074/JBC.M312452200

1 reference

5 December 2017

1 reference